scispace - formally typeset
R

Rithy Sem

Researcher at Pasteur Institute

Publications -  16
Citations -  1417

Rithy Sem is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Plasmodium falciparum & Mefloquine. The author has an hindex of 15, co-authored 16 publications receiving 1348 citations.

Papers
More filters
Journal ArticleDOI

Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia.

TL;DR: The results suggest that artesunate-mefloquine combination therapy is beginning to fail in southern Cambodia and that resistance is not confined to the provinces at the Thai-Cambodian border.
Journal ArticleDOI

Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the cambodian–thai border

TL;DR: Artemisinin combination therapies have recently been adopted as first-line therapy for Plasmodium falciparum infections in most malaria-endemic countries and should be evaluated further as a surveillance tool for artesunate-mefloquine resistance in Cambodia.
Journal ArticleDOI

Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.

TL;DR: Artesunate and mefloquine combination treatment has been used since 2000 in Cambodia as the first‐line drug for the treatment of uncomplicated falciparum malaria and side effects were common, especially dizziness, but were mild and transient and patients recovered without any medical intervention.
Journal ArticleDOI

Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing.

TL;DR: In this paper, the authors used massively parallel pyrosequencing to characterize malaria parasite diversity in the infections of a group of patients and showed that the in-host diversity revealed by this method far exceeded that described by currently recommended genotyping methods, with as many as sixfold more variants per infection.